Blood test breakthrough: tiny molecules may spot liver cancer early
NCT ID NCT07404566
First seen Feb 11, 2026 · Last updated May 25, 2026 · Updated 14 times
Summary
This study looked at whether measuring specific microRNAs in the blood can help diagnose liver cancer in people with hepatitis C. Researchers tested 84 participants, including healthy controls and patients with hepatitis C, cirrhosis, or liver cancer. They measured levels of five microRNAs to see how accurately they could tell liver cancer apart from other liver conditions. The goal is to find a better, less invasive screening tool than current blood tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alexandria Faculty of medicine
Alexandria, El Alexandria, 21512, Egypt
Conditions
Explore the condition pages connected to this study.